- Home
- SGMO vs IRWD Comparison
SGMO vs IRWD Comparison
Compare SGMO & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- IRWD
- Stock Information
- Founded
- SGMO 1995
- IRWD 1998
- Country
- SGMO United States
- IRWD United States
- Employees
- SGMO N/A
- IRWD N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- SGMO Health Care
- IRWD Health Care
- Exchange
- SGMO Nasdaq
- IRWD Nasdaq
- Market Cap
- SGMO 122.8M
- IRWD 111.2M
- IPO Year
- SGMO 2000
- IRWD 2010
- Fundamental
- Price
- SGMO $0.59
- IRWD $0.82
- Analyst Decision
- SGMO Buy
- IRWD Buy
- Analyst Count
- SGMO 6
- IRWD 5
- Target Price
- SGMO $4.50
- IRWD $4.94
- AVG Volume (30 Days)
- SGMO 5.2M
- IRWD 1.5M
- Earning Date
- SGMO 08-05-2025
- IRWD 08-07-2025
- Dividend Yield
- SGMO N/A
- IRWD N/A
- EPS Growth
- SGMO N/A
- IRWD N/A
- EPS
- SGMO N/A
- IRWD N/A
- Revenue
- SGMO $63,756,000.00
- IRWD $317,676,000.00
- Revenue This Year
- SGMO $1.29
- IRWD N/A
- Revenue Next Year
- SGMO $1.60
- IRWD N/A
- P/E Ratio
- SGMO N/A
- IRWD N/A
- Revenue Growth
- SGMO 239.92
- IRWD N/A
- 52 Week Low
- SGMO $0.41
- IRWD $0.53
- 52 Week High
- SGMO $3.18
- IRWD $7.11
- Technical
- Relative Strength Index (RSI)
- SGMO 60.91
- IRWD 56.06
- Support Level
- SGMO $0.50
- IRWD $0.67
- Resistance Level
- SGMO $0.65
- IRWD $0.92
- Average True Range (ATR)
- SGMO 0.04
- IRWD 0.07
- MACD
- SGMO 0.01
- IRWD 0.01
- Stochastic Oscillator
- SGMO 64.22
- IRWD 58.52
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.